devdiscourse13h
Celecoxib Boosts Survival Odds for Colon Cancer Patients
Recent research indicates that colon cancer patients with circulating tumor DNA post-surgery may improve their survival likelihood with daily celecoxib use. Celecoxib, a COX-2 inhibitor, significantly ...
Natera’s Advancements in ctDNA/MRD and Signatera’s Potential Drive Buy Rating
Leerink Partners analyst Puneet Souda has maintained their bullish stance on NTRA stock, giving a Buy rating yesterday.Invest with Confidence: ...
Blood test could guide use of anti-inflammatory drug celecoxib to reduce risk of colon cancer recurrence
A data analysis from a randomized clinical trial for stage 3 colon cancer patients by investigators at Dana-Farber Brigham ...
Billboard14d
Billboard 200â„¢
The week’s most popular albums as compiled by Luminate, based on multi-metric consumption (blending traditional album sales, track equivalent albums, and streaming equivalent albums). Lil Baby ...
Medscape22d
Perioperative Celebrex Administration for Pain Management After Total Knee Arthroplasty — A Randomized, Controlled Study
In our study, we found that perioperative administration of celecoxib, a selective COX-2 inhibitor, reduced postoperative VAS pain scores at rest and decreased morphine usage while providing ...
CNET27d
31 Best Gifts Under $200 for 2025
Desiree DeNunzio is the gift guide editor for CNET's Commerce team. When she's not writing and editing, she's either hiking through the redwoods or curled up with a good book and a lazy dog ...